Skip to main content

Advertisement

ADVERTISEMENT

News

MiMedx Group 

https://investors.mimedx.com/news-releases/news-release-details/mimedx-announces-second-quarter-2024-operating-and-financial

MiMedx management noted that the increase in revenue was partially offset by commercial challenges due to sales of artificially high-priced skin substitute products by competitors, the uncertainty of Medicare reimbursements and sales team turnover. Q224 MDXG Earning Release

Advertisement

Advertisement

Advertisement